Quinn William P.'s Form 4 filing
Bolt Biotherapeutics, Inc. (BOLT) · filed Oct 24, 2025
- Accession no.
- 0001193125-25-250332
- Filed
- Oct 24, 2025
- Trade date
- Jun 6-Oct 22, 2025
- Filing delay
- 140 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $686.25. It was filed 140 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Quinn William P.CIK 0001724190 | Director, Officer (President, CEO and CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 6, 2025 | Common Stock | PPurchaseAcquired | +125 | $5.49 | +$686.25 | 2,188 | Direct | |
| Oct 22, 2025 | Common Stock | AGrant or awardAcquired | +40,000 | $0.00 | $0 | 42,188 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.